July Emerging Medical Technologies Report

•1-A liquid biopsy, for the isolation, enumeration, and retrieval of viable circulating tumor cells (CTCs) from blood and 2-A cell-based in vitro diagnostic device for the cancer research market
•1-Diagnostic assays for the practical delivery of personalized medicine and 2-Companion diagnostics (CDx)
•A bioresorbable scaffold for treating peripheral artery disease (PAD) in the superficial femoral artery (SFA)
•A humanized monoclonal antibody with a unique mechanism of action, which is being developed for the treatment of Inflammatory Bowel Disease (IBD), Rheumatoid Arthritis (RA), and other autoimmune diseases
•A line of innovative consumer-oriented ear products based on a drug delivery system that addresses the inherent limitations of ear drops
•A temporary wound closure device to control severe bleeding within seconds of application at the point-of-injury
•Ambient Assisted Living System (AALS) that monitors a senior's daily activity by observing usage of any 3 electrical appliances, such as: a microwave, television, or lamp
•An advanced, continuous, automatic, and real-time breath-testing platform that enables the detection of the Helicobacter pylori bacteria, assessment of liver function across a range of clinical conditions, and gastric emptying
•Anti-bacterial barrier technology to reduce recurrent urinary tract infections (UTIs) in women
•Biologic medicines primarily for the treatment of oncology and inflammatory diseases
•Computer-based systems that provide a quick, accurate, non-invasive, and low-cost method for the early detection of Alzheimer's Disease (AD) and for precise measurement of disease progression
•Dental and orthopedic implant products
•Devices for diagnosing and treating swallowing disorders
•Drug design strategies delivered via unique dermal product solutions to treat neurological and a variety of other disorders
•External tissue expansion devices for the wound care market
•First-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors
•Fractional flow reserve (FFR) guidewire that provides an easier, more effective, and more affordable way to obtain FFR measurements during coronary catheterization procedures
•Home-use devices incorporating a proprietary platform technology for the treatment of obstructive sleep apnea (OSA) and other sleep-related disorders
•Minimally invasive device-based therapies for treating chronic diseases
•Minimally invasive energy-based treatment approach (electroporation) that causes tumor tissue to become up to 1000-fold more porous and capable of absorbing certain chemotherapy drugs without damaging healthy tissues
•Minimally invasive treatment for nasal valve collapse
•Neurostimulation technology for the treatment of chronic respiratory insufficiency: 1-from spinal cord injuries, 2-from muscular dystrophies (such as Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig's Disease), and 3-in a short-term intensive care setting
•Non-invasive and non-pharmacologic technology that treats or prevents symptoms of serious headache conditions and bronchoconstriction by sending a mild electrical signal through the skin to stimulate the vagus nerve
•Personal hygiene product for the discreet protection of accidental bowel leakage
•Platform technology that enables local, targeted delivery of botulinum toxin (Botox) and other potent macromolecules across the skin without patches, needles or other invasive procedures
•Proprietary technology for the oral delivery of drugs presently administered by way of injection
•Pulmonary vein implants for treating atrial fibrillation (AF)
•Quality spine products for treating serious orthopedic medical conditions in a cost-effective manner
•Technology for heart repair procedures
•Wirelessly powered micro implantable stimulators to provide pain relief